Aethlon Medical Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Aethlon Medical, Inc. on October 16, 2025. The report details a material modification to the rights of security holders involving a 1-for-10 reverse stock split of the Company's common stock.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only quantitative data provided relates to capitalization:
- Pre-Split Outstanding Shares: 7,612,106 shares as of October 16, 2025.
- Post-Split Outstanding Shares: Approximately 761,210 shares (subject to rounding adjustments).
- Pre-Split Authorized Shares: 60,000,000 shares.
- Post-Split Authorized Shares: 6,000,000 shares.
Material Changes
The primary material change is the implementation of a 1-for-10 reverse stock split, effective October 16, 2025, at 10:00 a.m. Eastern Time. Key operational changes include:
- Trading Symbol: Remains "AEMD" on The Nasdaq Capital Market.
- CUSIP Number: Changed to 00808Y604.
- Trading Resumption: Expected to begin on a split-adjusted basis on October 20, 2025.
- Fractional Shares: No fractional shares will be issued; holders entitled to fractions will receive one whole share instead.
- Adjustments: All outstanding options, warrants, and convertible securities will be appropriately adjusted.
Management Commentary and Risks
Reason for Action: Management states the reverse stock split is part of the Company's overall capital-markets and operating plan, specifically for dilution management and to maintain compliance with Nasdaq Listing Rule 5550(a)(2).
Stockholder Impact: The Company notes that each stockholder's percentage ownership and proportional voting power will remain virtually unchanged, except for minor adjustments due to rounding. No stockholder approval was required under Nevada law.
Risks/Contingencies: The filing does not explicitly list new risks or contingencies beyond the standard mechanics of the split.
Investor Verification Checklist
- Verify the new CUSIP number (00808Y604) with your brokerage to ensure proper account updates.
- Confirm the number of shares held post-split, noting that fractional shares are rounded up to one whole share.
- Check the trading status of AEMD on October 20, 2025, to confirm the split-adjusted price and volume.
- Review the adjustment terms for any outstanding options or warrants held.